NFE2L3 Antikörper (AA 351-400)
Kurzübersicht für NFE2L3 Antikörper (AA 351-400) (ABIN1103247)
Target
Alle NFE2L3 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 351-400
-
Marke
- IHC-plus™
-
Spezifität
- Human NFE2L3
-
Homologie
- Percent identity by BLAST analysis: Human (100%) Mouse, Dog, Rabbit (92%) Bovine (85%).
-
Aufreinigung
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide located between aa351-400 of human NFE2L3 (Q9Y4A8, NP_004280). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Galago (100%), Gibbon, Monkey, Mouse, Dog, Bat, Rabbit (92%), Elephant, Bovine, Guinea pig (85%).
Type of Immunogen: Synthetic peptide -
Isotyp
- IgG
-
-
anti-Nuclear Factor (erythroid-Derived 2)-Like 3 (NFE2L3) (AA 666-694), (C-Term) antibody
NFE2L3 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB41576 unconjugated
anti-Nuclear Factor (erythroid-Derived 2)-Like 3 (NFE2L3) (AA 132-260) antibodyNFE2L3 Reaktivität: Human WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Nuclear Factor (erythroid-Derived 2)-Like 3 (NFE2L3) (C-Term) antibodyNFE2L3 Reaktivität: Human WB, ELISA, ICC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Nuclear Factor (erythroid-Derived 2)-Like 3 (NFE2L3) (AA 300-550) antibodyNFE2L3 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- Approved: IHC, IHC-P (2.5 - 5 μg/mL), WB (0.2 - 1 μg/mL)
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Reconstitute with 50 μL sterile ddH2O.
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized from PBS with 2 % sucrose
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
-
